Rate My Professor Libby Hotham

Dr Elizabeth (Libby) Hotham serves as Adjunct Senior Lecturer in Clinical and Health Sciences in the School of Pharmacy and Biomedical Sciences, College of Health, at Adelaide University. She holds a Bachelor of Pharmacy (BPharm), Master of Applied Science in Pharmacy (MAppSc Pharmacy), and PhD. A registered pharmacist for several decades, Hotham has extensive practical experience in community pharmacy sectors in Queensland and South Australia, as well as positions at two public hospitals in Adelaide. Her academic career includes eleven years of teaching at TAFE in Adelaide's western suburbs, with a primary focus on alcohol and other drugs education. She worked in the School of Pharmacy and Medical Sciences during the early 1990s, returned in December 2002, and held the position of Program Director for the Bachelor of Pharmacy (Honours) from mid-2005 to mid-2017. Additionally, she contributed at the National Centre for Education and Training in Addiction at Flinders University and supported the education of pharmacists at the University of South Australia.

Hotham's research specializations encompass the multifaceted care of mental health clients across diverse sectors, including community pharmacy; harm minimization initiatives within pharmacy; diagnosis of ADHD and psychostimulant use; medication utilization among the elderly; adherence to heart failure medications; and mental health system-wide initiatives. Her scholarly output includes key publications such as Moore et al., 'Psychotropic Polypharmacy and QT Prolonging Medications in Hospitalized Patients' (Pharmacology Research and Perspectives, 2025); Bui et al., 'Metabolic monitoring for adults living with a serious mental illness on a second-generation antipsychotic agent: a scoping review' (Administration and Policy in Mental Health and Mental Health Services Research, 2025); Cooper et al., 'Peer support as a potential tool to promote pharmacists’ wellbeing' (Journal of the American Pharmacists Association, 2024); Singleton et al., 'Consumer knowledge of mental health conditions, awareness of mental health support services, and perception of community pharmacists' role in mental health promotion' (International Journal of Pharmacy Practice, 2024); Au et al., 'Changes in sedative burden at discharge in hospitalised patients experiencing psychotropic polypharmacy' (Schizophrenia Research, 2024); and Au et al., 'Guidelines and treatment for illicit drug related presentations in emergency departments: A scoping review' (Australasian Psychiatry, 2023), among others addressing pharmacy's role in mental health, COVID-19 impacts, and medication management from 2021 to 2025.